tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market
RARE
Ultragenyx Pharmaceutical
RESEARCH TOOLSreports

Ultragenyx Pharmaceutical (RARE) Stock News & Sentiment

Compare
1,201 Followers
Ultragenyx Highlights New UX111 Data in FDA Resubmission
Premium
Company Announcements
Ultragenyx Highlights New UX111 Data in FDA Resubmission
1d ago
8K
RARE
Ultragenyx: Advancing Rare Disease Pipeline, Key 2026–2027 Catalysts, and Path to Profitability Support Buy Rating
Premium
Ratings
Ultragenyx: Advancing Rare Disease Pipeline, Key 2026–2027 Catalysts, and Path to Profitability Support Buy Rating
1d ago
RARE
Ultragenyx Resubmits UX111 Gene Therapy for FDA Review
Premium
Company Announcements
Ultragenyx Resubmits UX111 Gene Therapy for FDA Review
5d ago
8K
RARE
Ultragenyx: Better‑Than‑Expected Revenue, Strengthened Liquidity, and Upcoming Pipeline Catalysts Support Maintained Buy Rating
Premium
Ratings
Ultragenyx: Better‑Than‑Expected Revenue, Strengthened Liquidity, and Upcoming Pipeline Catalysts Support Maintained Buy Rating
23d ago
RARE
Ultragenyx: Trial Setback Creates Buying Opportunity as Diversified Pipeline and Commercial Base Support $60 Target
Premium
Ratings
Ultragenyx: Trial Setback Creates Buying Opportunity as Diversified Pipeline and Commercial Base Support $60 Target
1M ago
RARE
Ultragenyx completes BLA filing for GSDIa gene therapy
Premium
Company Announcements
Ultragenyx completes BLA filing for GSDIa gene therapy
1M ago
8K
RARE
Ultragenyx: Refocusing on Apazunersen and Strengthened Balance Sheet Support Buy Rating Despite OI Setback
Premium
Ratings
Ultragenyx: Refocusing on Apazunersen and Strengthened Balance Sheet Support Buy Rating Despite OI Setback
1M ago
RARE
More RARE News >

RARE News on the Web

Insider Sell: Howard Horn Sells Shares of Ultragenyx Pharmaceutical Inc (RARE)
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: High Tide (HITI), Ultragenyx Pharmaceutical (RARE) and Kymera Therapeutics (KYMR)
TipRanks News
Bullish
Ultragenyx Resubmits UX111 Gene Therapy for FDA Review
TipRanks News
Neutral
Ultragenyx resubmits BLA for UX111 gene therapy with FDA
TipRanks News
Bullish
Ultragenyx assumed with an Overweight at Barclays
TipRanks News
Bullish
Bank of America Securities Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV), Ultragenyx Pharmaceutical (RARE) and Teva Pharmaceutical (TEVA)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Ultragenyx Pharmaceutical (RARE) and Teva Pharmaceutical (TEVA)
TipRanks News
Bullish

News Score - Last 7 Days

Positive
RARE
Sector Average
Media Buzz
This Week4 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RARE’s Media Buzz Sentiment?
4 articles about RARE were published this week. In an average week, 4.25 articles are published.
    What is RARE’s weekly average amount of articles?
    In an average week, 4.25 articles about RARE are published.
      What is RARE’s News Sentiment?
      100% of articles about RARE were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        EGHT8X8
        DOXAmdocs
        4373Simplex Holdings,Inc.
        9759NSD Co., Ltd.
        VUZIVuzix
        Showing the stocks with the most bullish news sentiment over the past week